Shares of Johnson & Johnson (NYSE: JNJ) are tumbling on Tuesday. The company's stock lost 6.3% as of 2:25 p.m. ET. The drop comes as the S&P 500 and Nasdaq Composite were down 0.4% and 0.1%, respectively.
The healthcare giant was rebuffed by a judge in its latest attempt to settle its yearslong legal battle.
Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Learn More »
A bankruptcy judge in Texas dismissed J&J's latest attempt to settle thousands of lawsuits that allege its baby powder and other talc-based products caused ovarian cancer. The $10 billion settlement was rejected by Judge Christopher Lopez, who ruled that the company didn't offer enough time to properly collect the votes it needed from claimants.
There are tens of thousands of claimants and a majority would have needed to vote to accept the proposed settlement, which J&J claims it had. The judge said, however, that the "unreasonably short voting time" made the votes suspect and that at least half of the votes "cannot count." This marks the third time Johnson & Johnson's bankruptcy strategy has failed in court.
Following the ruling, Johnson & Johnson announced it would return to the courts to fight the cases individually and "defeat merciless talc claims." The company has maintained that its products do not cause cancer and maintained ignorance of its baby powder containing cancer-causing asbestos. According to the lawsuits and investigative reporting from Reuters, the company not only knew, but actively kept the information from regulators and the public.
I would stay away from the stock until more information comes to light.
Before you buy stock in Johnson & Johnson, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Johnson & Johnson wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $664,271!*
Stock Advisor provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month. The Stock Advisor service has more than quadrupled the return of S&P 500 since 2002*. Don’t miss out on the latest top 10 list, available when you join Stock Advisor.
See the 10 stocks »
*Stock Advisor returns as of April 1, 2025
Johnny Rice has no position in any of the stocks mentioned. The Motley Fool recommends Johnson & Johnson. The Motley Fool has a disclosure policy.